Heme-mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin.
Catalysis of the formation of reactive oxygen species (RO2S) by low molecular weight complexes of iron has been implicated in several pathological conditions in the retina since photoreceptors and retinal pigment epithelial cells are likely to be especially sensitive to RO2S. Since protective proteins cannot cross the blood-retinal barrier, it is likely that the retina performs its own protective functions by synthesizing proteins that bind iron and nonprotein iron complexes, the major catalysts of RO2S generation. Investigations were carried out to determine whether pigment epithelial cells are themselves sensitive to iron-generated RO2S and whether apo-transferrin and apo-hemopexin, known to be made locally in the retina, can perform a protective function. In 51Cr release assays, the toxicity of exogenous RO2S including hydrogen peroxide or superoxide (generated by xanthine oxidase/hypoxanthine) to human retinal pigment epithelial cells was inhibited by the iron chelators, desferrioxamine and apo-transferrin. Free but not protein-bound ferric iron and heme exacerbated the toxic effect. The toxic effect of heme was abolished by the heme-scavenging, extracellular antioxidant, apo-hemopexin, and also by exogenous bovine serum albumin. In addition, heme toxicity was inhibited by a 3 h preincubation of cells with either heme, apo-hemopexin, or heme-hemopexin 24 h prior to the toxicity assay. It is concluded, first, that toxic effects of iron and heme can be prevented by apo-transferrin or apo-hemopexin and, second, that exposure of RPE cells to free heme or hemopexin sets in motion a series of biochemical events resulting in protection against oxidative stress. It is probable that these include heme oxygenase induction.
Hunt
R C
RC
Department of Microbiology and Immunology, University of South Carolina School of Medicine, Columbia 29208, USA.
Handy
I
I
Smith
A
A
D000975:Antioxidants; D001059:Apoproteins / Q000502:physiology; D002478:Cells, Cultured; D005290:Ferric Compounds / Q000633:toxicity; D006418:Heme / Q000633:toxicity; D006427:Hemin / Q000633:toxicity; D006466:Hemopexin / Q000502:physiology*; D006801:Humans; D010857:Pigment Epithelium of Eye / Q000187:drug effects / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000633:toxicity*; D013481:Superoxides / Q000633:toxicity
D000975:Antioxidants; D001059:Apoproteins; D005290:Ferric Compounds; D017382:Reactive Oxygen Species; D013481:Superoxides; D006418:Heme; D006427:Hemin; D006466:Hemopexin